AU684817B2 - Benzopyrans and pharmaceutical compositions containing them - Google Patents

Benzopyrans and pharmaceutical compositions containing them Download PDF

Info

Publication number
AU684817B2
AU684817B2 AU74948/94A AU7494894A AU684817B2 AU 684817 B2 AU684817 B2 AU 684817B2 AU 74948/94 A AU74948/94 A AU 74948/94A AU 7494894 A AU7494894 A AU 7494894A AU 684817 B2 AU684817 B2 AU 684817B2
Authority
AU
Australia
Prior art keywords
formula
compound
dihydro
alkyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU74948/94A
Other languages
English (en)
Other versions
AU7494894A (en
Inventor
Alexander Roderick Mackenzie
Sandra Marina Monaghan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Research and Development Co NV SA
Original Assignee
Pfizer Research and Development Co NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Research and Development Co NV SA filed Critical Pfizer Research and Development Co NV SA
Publication of AU7494894A publication Critical patent/AU7494894A/en
Application granted granted Critical
Publication of AU684817B2 publication Critical patent/AU684817B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU74948/94A 1993-08-04 1994-07-18 Benzopyrans and pharmaceutical compositions containing them Ceased AU684817B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans
GB9316111 1993-08-04
PCT/EP1994/002387 WO1995004730A1 (en) 1993-08-04 1994-07-18 Benzopyrans and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
AU7494894A AU7494894A (en) 1995-02-28
AU684817B2 true AU684817B2 (en) 1998-01-08

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74948/94A Ceased AU684817B2 (en) 1993-08-04 1994-07-18 Benzopyrans and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (2) US5912244A (cs)
EP (1) EP0712398B1 (cs)
JP (1) JP2871098B2 (cs)
KR (1) KR0175532B1 (cs)
CN (1) CN1128536A (cs)
AT (1) ATE152716T1 (cs)
AU (1) AU684817B2 (cs)
CA (1) CA2168563C (cs)
CO (1) CO4230234A1 (cs)
CZ (1) CZ281853B6 (cs)
DE (1) DE69403084T2 (cs)
DK (1) DK0712398T3 (cs)
EC (1) ECSP941140A (cs)
EG (1) EG20525A (cs)
ES (1) ES2102870T3 (cs)
FI (1) FI960487A0 (cs)
GB (1) GB9316111D0 (cs)
GR (1) GR3023521T3 (cs)
HU (1) HUT75120A (cs)
IL (1) IL110488A (cs)
NO (1) NO960441L (cs)
NZ (1) NZ271344A (cs)
PE (1) PE56894A1 (cs)
PL (1) PL312788A1 (cs)
SG (1) SG42817A1 (cs)
TW (1) TW333532B (cs)
WO (1) WO1995004730A1 (cs)
ZA (1) ZA945774B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
KR100314986B1 (ko) * 1996-06-07 2002-01-12 반더빌트유니버시티 항염증제로서 유용한 디히드로벤조피란및 관련화합물
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
IL158262A0 (en) * 2001-04-16 2004-05-12 Schering Corp 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
CN1561338A (zh) * 2001-10-04 2005-01-05 惠氏公司 作为5－羟基色胺－6配体的苯并二氢吡喃衍生物
KR20050074592A (ko) * 2002-11-12 2005-07-18 워너-램버트 캄파니 엘엘씨 벤조피란을 사용한 모발 성장의 자극 방법
JP2007522201A (ja) * 2004-02-12 2007-08-09 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 毛成長の刺激方法
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
WO2006008641A1 (en) * 2004-07-16 2006-01-26 Warner-Lambert Company Llc Hair growth promoting agents
MXPA06014390A (es) * 2004-07-19 2007-10-02 Warner Lambert Co Formulacion para estimular el crecimiento del pelo.
JP4738418B2 (ja) * 2004-12-21 2011-08-03 エフ．ホフマン−ラ ロシュ アーゲー クロマン誘導体及びｃｎｓ障害の処置におけるその使用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3818989A (en) * 1988-07-19 1990-01-25 Hoechst Aktiengesellschaft The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
AU5600790A (en) * 1989-06-02 1990-12-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Chromanderivate
AU3017192A (en) * 1991-12-14 1993-06-17 Hoechst Aktiengesellschaft Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3881714D1 (de) * 1987-02-04 1993-07-22 Hoechst Ag Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
JPH0673061A (ja) * 1992-01-18 1994-03-15 Hoechst Ag ６−置換クロメン類のエナンチオ選択的エポキシ化方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3818989A (en) * 1988-07-19 1990-01-25 Hoechst Aktiengesellschaft The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
AU5600790A (en) * 1989-06-02 1990-12-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Chromanderivate
AU3017192A (en) * 1991-12-14 1993-06-17 Hoechst Aktiengesellschaft Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases

Also Published As

Publication number Publication date
TW333532B (en) 1998-06-11
IL110488A0 (en) 1994-10-21
FI960487A7 (fi) 1996-02-02
KR0175532B1 (ko) 1999-02-18
US5912244A (en) 1999-06-15
NZ271344A (en) 1997-10-24
CO4230234A1 (es) 1995-10-19
CZ281853B6 (cs) 1997-02-12
AU7494894A (en) 1995-02-28
ATE152716T1 (de) 1997-05-15
DK0712398T3 (da) 1997-10-27
JPH08508042A (ja) 1996-08-27
ES2102870T3 (es) 1997-08-01
WO1995004730A1 (en) 1995-02-16
IL110488A (en) 1999-08-17
US6071938A (en) 2000-06-06
DE69403084T2 (de) 1997-08-14
FI960487L (fi) 1996-02-02
SG42817A1 (en) 1997-10-17
GB9316111D0 (en) 1993-09-22
JP2871098B2 (ja) 1999-03-17
CA2168563C (en) 1999-09-07
ECSP941140A (es) 1995-01-16
DE69403084D1 (de) 1997-06-12
PL312788A1 (en) 1996-05-13
FI960487A0 (fi) 1996-02-02
EG20525A (en) 1999-06-30
CA2168563A1 (en) 1995-02-16
NO960441D0 (no) 1996-02-02
EP0712398B1 (en) 1997-05-07
CZ33196A3 (en) 1996-05-15
PE56894A1 (es) 1995-02-07
CN1128536A (zh) 1996-08-07
HUT75120A (en) 1997-04-28
ZA945774B (en) 1996-02-05
EP0712398A1 (en) 1996-05-22
NO960441L (no) 1996-02-02
GR3023521T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
KR960009434B1 (ko) 3-데메틸메발론산 유도체, 이의 제조방법 및 중간체
AU684817B2 (en) Benzopyrans and pharmaceutical compositions containing them
EP0093535B1 (en) Novel chromenes and chromans
US4542149A (en) 4-Amino-benzo[b]pyran-3-ol derivatives
US5447946A (en) Hydantoin derivatives for treating complications of diabetes
US20100069379A1 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
HUT71558A (en) Pyran-2-one- and 5,6-dihydro-pyran-2-one derivatives for treating hiv- and other retrovirus infections
WO1997028161A1 (en) Novel pyrrolo[2,3-d]pyrimidines and their use as tyrosine kinase inhibitors
HK17588A (en) Pharmaceutically active benzopyran compounds
HU213186B (en) Process for the preparation of fenoxy-pyrimidine derivatives
JPH07110853B2 (ja) 抗ウイルス化合物および抗高血圧化合物
EP0550464A1 (en) Antiviral compounds and antihypertensive compounds
EP0030156B1 (en) Quinazoline derivatives, processes for their preparation and pharmaceutical compositions containing them
US4062870A (en) Chroman derivatives
US5179093A (en) Quinoline-diones
AU3634997A (en) Chroman derivatives
EP0745071B1 (en) 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
RU2122000C1 (ru) Бензопираны, промежуточные соединения, фармацевтическая композиция и способ лечения
AU674940B2 (en) Benzopyranes as potassium channel openers
US4591588A (en) Triazolo[1,5-c]pyrimidines and bronchodilation use thereof
JPH0480027B2 (cs)
CA2129813C (en) 5-aminoflavone derivatives
JP3468589B2 (ja) ５−アミノフラボン誘導体
US5064831A (en) Naphthothiophenimines for treating neuronal disorders caused by ischemia
US4985573A (en) Hydantoin derivatives for treating complications of diabetes

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired